FDA Drug Application (021351) for OXYTROL by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number021351
Product Number002
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage3.9MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOXYTROL
Active IngredientOXYBUTYNIN

Active IngredientCount
List of drugs with Active Ingredient OXYBUTYNIN4


Back to FDA Applications sponsored by ALLERGAN SALES LLC